RLAY vs SNPS · rev $3.4M vs P/E 63, rev $7.16B
Relay Therapeutics Inc (RLAY) versus Synopsys Inc (SNPS) — a side-by-side from cached financials, not a winner call.
Relay Therapeutics Inc (RLAY) is a biotechnology company listed on NASDAQ.
Synopsys Inc (SNPS) is a software - infrastructure company listed on US.
Latest reported RLAY revenue for 2026-06-30 was $3.4M. Net income was -$157.0M. Revenue was up 11.7% from 2026-03-31 to 2026-06-30. RLAY currently screens at market cap $3.39B.
Latest reported SNPS revenue for 2026-07-31 was $7.16B. Net income was $627.9M. Revenue was up 52.9% from 2026-04-30 to 2026-07-31. SNPS currently screens at market cap $85.14B and trailing P/E 63.3.
RLAY currently screens at market cap $3.39B. SNPS currently screens at market cap $85.14B and trailing P/E 63.3.
Not investment advice. Open the RLAY and SNPS stock pages for the full models.
Not investment advice.